Coronary-Vessel Regeneration
Safely restore the blood vessels that feed the heart
The goal is to safely restore the coronary vessels — the arteries that feed the heart muscle itself — regrowing the supply that heart disease narrows or closes, with no new health problems. Restoring the heart’s own blood flow, not only routing around blockage. This page maps each pathway with the science behind it.
The heart muscle has its own dedicated arteries — the coronary vessels. When they narrow or close, heart muscle starves: this is the mechanism of most heart attacks. For most of medicine’s history, blocked coronaries could only be bypassed or propped open. But the same vessel-growing biology that regenerates circulation elsewhere applies here: the heart can grow new coronary supply (collateral vessels), and the science of stimulating that is advancing. Each pathway below names its science and stage.
We are building the capability to safely restore coronary supply: supporting the heart’s own collateral-vessel growth, stimulating new coronary vessels, and — at the frontier — regenerating coronary vasculature, so the heart muscle is re-supplied rather than only relieved.
Each restoration pathway — capability, science, and stage
Supporting collateral-vessel growth Demonstrated — clinical
The science: the heart can grow collateral vessels — natural detours around narrowed arteries — and physical activity stimulates this growth. Supporting the heart’s own coronary angiogenesis is the most grounded route to restoring supply, linked to cardiac resilience.
Protecting the coronary lining Demonstrated — clinical
The science: coronary disease begins in the endothelium — the vessel lining; protecting and restoring it (see vessel-wall repair) keeps coronaries open and able to regrow. Endothelial health is coronary health.
Stimulating coronary angiogenesis Clinical / Frontier
The science: therapeutic angiogenesis applied to the heart aims to grow new coronary vessels by delivering pro-growth signals to under-supplied heart muscle — an emerging strategy advancing through research toward people.
Mobilizing vessel-builder cells for the heart Frontier
The work: endothelial progenitor cells can promote new-vessel growth in the heart; a 2025 meta-analysis of injury models found they enhanced angiogenesis and improved cardiac function measures. Advancing, with human results still mostly ahead, and labeled frontier.
Rebuilding coronary vasculature Frontier
The frontier: the broader vascular regeneration science — reprogramming and engineered vessels — aims to rebuild coronary supply where the body cannot. Advancing in the lab, honestly not yet routine in people.
Restoring heart blood flow, not just vessels Clinical / Frontier
The north star: success means the heart muscle is actually re-supplied — measured as restored coronary flow and recovered function. Genuine reperfusion, achieved safely, is the measure, and the link to heart-function restoration.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
the National Heart, Lung, and Blood Institute (NHLBI, NIH), which funds coronary and cardiovascular-regeneration research (all mechanisms).
Coronary angiogenesis researchers
Groups studying collateral-vessel growth and therapeutic angiogenesis in the heart (mechanisms 1, 3).
Endothelial & progenitor-cell researchers
Researchers advancing endothelial repair and EPC-driven vessel growth for the heart (mechanisms 2, 4).
Vascular-regeneration science
The broader reprogramming and tissue-engineering field behind rebuilding coronary vasculature (mechanism 5).
Enabling science
coronary angiogenesis and collateral biology · endothelial repair · endothelial progenitor cells · vascular tissue engineering.
The technologies: collateral-growth support (grounded, available today through activity), coronary therapeutic angiogenesis (advancing toward people), and the frontier of progenitor-cell and engineered-vessel regeneration — together aiming to restore the heart’s own supply. We name the stage of each.
The heart grows its own detours Demonstrated — clinical
The heart can grow collateral vessels around narrowed arteries — stimulated by activity, the grounded basis of restoring coronary supply.
Coronary angiogenesis is advancing Clinical / Frontier
Stimulating new coronary-vessel growth in under-supplied heart muscle is an emerging strategy moving through research.
Vessel-builder cells help the heart Frontier
EPCs enhanced angiogenesis and cardiac function measures in injury-model meta-analysis — promising, with human results ahead.
Rebuilding coronary supply is advancing Frontier
Reprogramming and engineered-vessel approaches aim to rebuild coronary vasculature in the lab — not yet routine in people.
The honest challenges: restoring coronary supply is real but mostly early. Collateral growth is genuine and supportable today, but stimulated and cell-based coronary regeneration are largely at the research and earliest-study stage, with much evidence in injury models and human results ahead. We are honest about that. But the direction is a genuine turning point: the heart’s own blood supply is becoming something we can begin to regrow, not only bypass.
The future, fully built
A future where the heart’s supply can be safely restored: collateral growth supported, the coronary lining protected, new vessels stimulated, and — as the frontier matures — coronary vasculature rebuilt. A starved heart becomes something we can re-supply, with no new health problems — not only route around.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Collateral-vessel growthDemonstrated (clinical)
The heart can grow collateral vessels around narrowed arteries, stimulated by physical activity — the grounded basis of restoring coronary supply.
Coronary therapeutic angiogenesisClinical / Frontier
Stimulating new coronary-vessel growth by delivering pro-growth signals to under-supplied heart muscle; an emerging strategy advancing through research.
EPCs for the heartFrontier
Endothelial progenitor cells enhanced angiogenesis and cardiac function measures in a 2025 injury-model meta-analysis; human results still mostly ahead.
Endothelial healthDemonstrated (clinical)
Coronary disease begins in the endothelium; protecting and restoring the lining keeps coronaries open and able to regrow.
Rebuilding coronary vasculatureFrontier
Reprogramming and engineered-vessel approaches aim to rebuild coronary supply where the body cannot; advancing in the lab.
Honest framing
Real organizations and research findings are cited as evidence the capability is real — not as partners or endorsers. The Healthy capability is the safe regeneration of healthy blood vessels, creating no new health problems. Where a step is frontier, we label it frontier.
Help build this future
Every signature grows the movement to make safe coronary-vessel restoration real — and free at the point of need.